mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
Bexarotene |
FIMM |
pan-cancer |
AAC |
-0.16 |
0.3 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
Ko-143 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.3 |
mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
0.038 |
0.3 |